CD40L in autoimmunity and mucosally induced tolerance
Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity
CD40L in autoimmunity and mucosally induced tolerance
Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity
Case 5-2003 — A 16-Year-Old Girl with a Rash and Chest Pain
Case 21-2002 — A 21-Year-Old Man with Arthritis during Treatment for Hyperthyroidism
Case 18-2001— A 19-Month-Old Boy with Fever and Soft-Tissue Masses
Corticotropin-releasing hormone regulates IL-6 expression during inflammation
Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
C-reactive protein: a critical update
Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation
Cytokines and cellular interactions in inflammatory synovitis
Decreased angiogenesis and arthritic disease in rabbits treated with an vß3 antagonist
Deficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice
Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis
Distinct roles for the NF-B1 (p50) and c-Rel transcription factors in inflammatory arthritis
Cases of Early Inflammatory Polyarthritis Should Not Be Classified as Having Rheumatoid Arthritis
Clinical Evaluation Versus Ultrasonography: Who Is the Winner?
Commentary: Do genes or environment influence development of rheumatoid arthritis?
COX 2 inhibitors may increase risk of heart attack ?
Crawling Through the Web: What Do Our Patients Find?
